title: A Case of Squamous Cell Carcinoma Harboring an EML4-ALK Rearrangement that Was Unsuccessfully Treated with the ALK Inhibitor Alectinib.
authors.affiliation: Department of Internal Medicine, National Hospital Organization Kinki-chuo Chest Medical Center, Osaka, Japan Department of Laboratory Medicine and Pathology, National Hospital Organization Kinki-chuo Chest Medical Center, Osaka, Japan Department of Clinical Research, National Hospital Organization Kinki-chuo Chest Medical Center, Osaka, Japan.
authors.forename: Akihiro
authors.initials: A
authors.lastname: Tamiya
authors.forename: Shigeki
authors.initials: S
authors.lastname: Shimizu
authors.forename: Shinji
authors.initials: S
authors.lastname: Atagi
mesh_terms: D000368:Aged; D002227:Carbazoles / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000235:genetics*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D008297:Male; D015514:Oncogene Proteins, Fusion / Q000235:genetics; D010880:Piperidines / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D017211:Treatment Failure
chemical_list: D002227:Carbazoles; C522504:EML4-ALK fusion protein, human; D015514:Oncogene Proteins, Fusion; D010880:Piperidines; D047428:Protein Kinase Inhibitors; C582670:alectinib